These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21663336)

  • 1. Adherence to biochemical monitoring recommendations in patients starting with renin angiotensin system inhibitors: a retrospective cohort study in the Netherlands.
    Bootsma JE; Warlé-van Herwaarden MF; Verbeek AL; Füssenich P; De Smet PA; Olde Rikkert MG; Kramers C
    Drug Saf; 2011 Jul; 34(7):605-14. PubMed ID: 21663336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical monitoring after initiation of aldosterone antagonist therapy in users of renin-angiotensin system blockers: a UK primary care cohort study.
    Sinnott SJ; Mansfield KE; Schmidt M; Bhaskaran K; Smeeth L; Nitsch D; Tomlinson LA
    BMJ Open; 2017 Nov; 7(11):e018153. PubMed ID: 29150471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study.
    Schmidt M; Mansfield KE; Bhaskaran K; Nitsch D; Sørensen HT; Smeeth L; Tomlinson LA
    BMJ Open; 2017 Jan; 7(1):e012818. PubMed ID: 28069618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney Function and Potassium Monitoring After Initiation of Renin-Angiotensin-Aldosterone System Blockade Therapy and Outcomes in 2 North American Populations.
    Parikh RV; Nash DM; Brimble KS; Markle-Reid M; Tan TC; McArthur E; Khoshniat-Rad F; Sood MM; Zheng S; Pravoverov L; Nesrallah GE; Garg AX; Go AS
    Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006415. PubMed ID: 32873054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe use of NSAIDs and RAS-inhibitors at Agogo Presbyterian Hospital, Ghana.
    Meulendijks LG; Adomako EA; Appiah EB; Kramers C
    Ghana Med J; 2016 Mar; 50(1):22-30. PubMed ID: 27605721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
    Ahmed A
    J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease.
    Garlo KG; Bates DW; Seger DL; Fiskio JM; Charytan DM
    JAMA Netw Open; 2018 Nov; 1(7):e183874. PubMed ID: 30646338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study.
    Fournier JP; Lapeyre-Mestre M; Sommet A; Dupouy J; Poutrain JC; Montastruc JL
    PLoS One; 2012; 7(3):e34187. PubMed ID: 22479557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes.
    Fu EL; Trevisan M; Clase CM; Evans M; Lindholm B; Rotmans JI; van Diepen M; Dekker FW; Carrero JJ
    Clin J Am Soc Nephrol; 2019 Sep; 14(9):1336-1345. PubMed ID: 31395593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-converting enzyme inhibitor-associated elevations in serum creatinine: is this a cause for concern?
    Bakris GL; Weir MR
    Arch Intern Med; 2000 Mar; 160(5):685-93. PubMed ID: 10724055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study.
    Mathieson L; Severn A; Guthrie B
    Scott Med J; 2013 May; 58(2):69-76. PubMed ID: 23728750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers.
    Raebel MA; McClure DL; Simon SR; Chan KA; Feldstein A; Andrade SE; Lafata JE; Roblin D; Davis RL; Gunter MJ; Platt R
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):55-64. PubMed ID: 16470693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to renal function monitoring guidelines in patients starting antihypertensive therapy with diuretics and RAAS inhibitors: a retrospective cohort study.
    van Blijderveen JC; Straus SM; de Ridder MA; Stricker BH; Sturkenboom MC; Verhamme KM
    Drug Saf; 2014 May; 37(5):369-77. PubMed ID: 24748427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of inhibitors of renin-angiotensin-aldosterone system (RAS) and combination therapy of steroids plus RAS inhibitors for patients with advanced immunoglobulin A nephropathy and impaired renal function.
    Moriyama T; Nakayama K; Ochi A; Amemiya N; Tsuruta Y; Kojima C; Itabashi M; Takei T; Uchida K; Nitta K
    Clin Exp Nephrol; 2012 Apr; 16(2):231-7. PubMed ID: 22038185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperkalemia After Initiating Renin-Angiotensin System Blockade: The Stockholm Creatinine Measurements (SCREAM) Project.
    Bandak G; Sang Y; Gasparini A; Chang AR; Ballew SH; Evans M; Arnlov J; Lund LH; Inker LA; Coresh J; Carrero JJ; Grams ME
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperkalemia and renal function during monotherapy and dual renin-angiotensin blockade in the community setting.
    Kurnik D; Vesterman-Landes J; Bialik M; Katzir I; Lomnicky Y; Halkin H; Loebstein R
    Clin Ther; 2011 Apr; 33(4):456-64. PubMed ID: 21635991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure.
    Kalra PA; Kumwenda M; MacDowall P; Roland MO
    BMJ; 1999 Jan; 318(7178):234-7. PubMed ID: 9915733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attainment of Guideline-Directed Medical Treatment in Stable Ischemic Heart Disease Patients With and Without Chronic Kidney Disease.
    Koutroumpakis E; Gosmanova EO; Stahura H; Jou S; Alreshq R; Ata A; Sidhu MS; Philbin E; Boden WE; Lyubarova R
    Cardiovasc Drugs Ther; 2019 Aug; 33(4):443-451. PubMed ID: 31123935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of European Society of Cardiology guidelines on medication profiles after hospitalization for heart failure in 22,476 Dutch patients: from 2001 until 2015.
    Kruik-Kollöffel WJ; Linssen GCM; Kruik HJ; Movig KLL; Heintjes EM; van der Palen J
    Heart Fail Rev; 2019 Jul; 24(4):499-510. PubMed ID: 30848404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.